|
|
Research Management and Support
|
RMS2008
|
$336,082,664
|
$4,808,250
|
N/A
|
National Cancer Institute
|
|
|
Training Program in Cancer Biology
|
5T32CA078207-10
|
$443,412
|
$150,760
|
AARONSON, STUART
|
MOUNT SINAI SCHOOL OF MEDICINE OF NYU
|
|
|
Modeling androgen-independent prostate cancer in mutant mice
|
7R01CA115717-02
|
$305,900
|
$305,900
|
Abate-Shen, Cory
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
|
A Mouse Model for Prostate Cancer
|
7U01CA084294-10
|
$1,446,104
|
$1,446,104
|
Abate-Shen, Cory
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
|
Modeling Prostate Tumorigenesis
|
2R01CA094858-06A1
|
$230,554
|
$230,554
|
Abdulkadir, Sarki
|
VANDERBILT UNIVERSITY
|
|
|
Role of Oncogenic Kinase Pim-1 in Prostate Cancer
|
5R01CA123484-02
|
$291,406
|
$291,406
|
Abdulkadir, Sarki
|
VANDERBILT UNIVERSITY
|
|
|
PHASE I SINGLE AND MULTIPLE-DOSE SAFETY AND PHARMACOKINETIC CLINICAL STUDY OF LYC
|
N01CN085081-008
|
|
$0
|
ABEITA, CATHY
|
University of Illinois at Chicago
|
|
|
Washington University Small Animal Imaging Resource
|
5U24CA083060-10
|
$633,099
|
$221,585
|
ACKERMAN, JOSEPH
|
WASHINGTON UNIVERSITY
|
|
|
HOWARD UNIVERSITY CANCER CENTER/JOHNS HOPKINS CANCER CENTER PARTNERSHIP
|
5U54CA091431-08
|
$1,535,549
|
$460,665
|
ADAMS-CAMPBELL, LUCILE
|
HOWARD UNIVERSITY
|
|
|
A Transgenic Model for Prostate Tumor Immunity
|
5R01CA109339-05
|
$281,848
|
$281,848
|
ADLER, ADAM
|
UNIVERSITY OF CONNECTICUT SCH OF MED/DNT
|
|
|
Prostate Cancer Prevention by Procyanidins in Grape Seed Extract
|
2R01CA091883-06A1
|
$334,640
|
$334,640
|
AGARWAL, CHAPLA
|
UNIVERSITY OF COLORADO DENVER
|
|
|
Prostate Cancer Chemoprevention by Inositol Hexaphosphate Efficacy and Mechanism
|
5R01CA116636-03
|
$261,397
|
$261,397
|
AGARWAL, RAJESH
|
UNIVERSITY OF COLORADO DENVER
|
|
|
Role of NCoR in Antiandrogen Resistance in Prostate Cancer
|
1R21CA129265-01A1
|
$207,225
|
$207,225
|
AGOULNIK, IRINA
|
BAYLOR COLLEGE OF MEDICINE
|
|
|
Targeting Relaxin Signaling in Prostate Cancer
|
5R21CA118362-02
|
$150,000
|
$150,000
|
Agoulnik, Alexander
|
BAYLOR COLLEGE OF MEDICINE
|
|
|
SELECT Pre-Clinical Trial of Prostate Cancer
|
5R01CA114060-03
|
$250,774
|
$250,774
|
Ahmad, Nihal
|
UNIVERSITY OF WISCONSIN MADISON
|
|
|
Phase III Trial of Selenium for Prostate Cancer Prevention
|
5R01CA077789-10
|
$588,097
|
$588,097
|
Ahmann, Frederick
|
UNIVERSITY OF ARIZONA
|
|
|
Studies of Normal and Neoplastic Prostate
|
5U01CA015062-33
|
$215,048
|
$215,048
|
AHMED, KHALIL
|
UNIVERSITY OF MINNESOTA TWIN CITIES
|
|
|
Participation in the Eastern Cooperative Oncology Group
|
5U10CA107868-05
|
$234,166
|
$2,342
|
AISNER, JOSEPH
|
UNIV OF MED/DENT NJ-R W JOHNSON MED SCH
|
|
|
North Carolina A&T University-Wake Forest Cancer Center partnership (2 of 2)
|
1P20CA138018-01
|
$135,639
|
$33,910
|
AKMAN, STEVEN
|
WAKE FOREST UNIVERSITY HEALTH SCIENCES
|
|
|
Training Program in Cancer Biology
|
5T32CA079448-09
|
$491,121
|
$245,561
|
AKMAN, STEVEN
|
WAKE FOREST UNIVERSITY HEALTH SCIENCES
|
|
|
SBIR TOPIC 236 PHASE 1 ANTIBODY ARRAY FOR CANCER DETECTION
|
N43CN800021-000
|
$149,995
|
$49,498
|
ALAM, MAKSUDUL
|
INNOSENSE, LLC
|
|
|
Prospective study of farmers and their families (Agricultural health study)
|
Z01 CP010119-02020
|
$1,233,935
|
$123,393
|
Alavanja, Michael
|
DCEG (NCI)
|
|
|
ATBC Study
|
Z01 CP010195-03031
|
$759,338
|
$227,801
|
Albanes, Demetrius
|
DCEG (NCI)
|
|
|
Comprehensive MRI, MRS and Molecular Analyses: Pten-based Prostate Cancer Models
|
5R01CA129003-02
|
$291,650
|
$291,650
|
ALBANESE, CHRISTOPHER
|
GEORGETOWN UNIVERSITY
|
|
|
Clinical Academic Oncologist Training Program
|
5K12CA087718-09
|
$446,225
|
$89,245
|
Albertini, Mark
|
UNIVERSITY OF WISCONSIN MADISON
|
|
|
Arizona Cancer Center Support Grant
|
3P30CA023074-30S5
|
$3,963,721
|
$356,735
|
ALBERTS, DAVID
|
UNIVERSITY OF ARIZONA
|
|
|
Arizona Cancer Center Support Grant
|
3P30CA023074-30S6
|
$100,000
|
$9,000
|
ALBERTS, DAVID
|
UNIVERSITY OF ARIZONA
|
|
|
Cancer Prevention and Control Training Grant
|
5R25CA078447-09
|
$511,052
|
$102,210
|
ALBERTS, DAVID
|
UNIVERSITY OF ARIZONA
|
|
|
CNP for Older Underserved African American Adults
|
3U01CA114583-04S1
|
$83,552
|
$20,888
|
ALBRECHT, TERRANCE
|
WAYNE STATE UNIVERSITY
|
|
|
Detroit CNP: "Social Network Analysis for CNP Partnerships"
|
3U01CA114583-04S2A1
|
$75,250
|
$18,813
|
ALBRECHT, TERRANCE
|
WAYNE STATE UNIVERSITY
|
|
|
CNP for Older Underserved African American Adults
|
5U01CA114583-04
|
$473,207
|
$118,302
|
ALBRECHT, TERRANCE
|
WAYNE STATE UNIVERSITY
|
|
|
CANCER INFORMATION SERVICE
|
N02CO511003-005
|
$630,200
|
$69,322
|
ALBRECHT, TERRANCE
|
WAYNE STATE UNIVERSITY
|
|
|
Immunotherapeutic Approaches to Cancer Treatment
|
1R41CA130493-01A1
|
$123,614
|
$123,614
|
ALEXANDER, RICHARD
|
VIROGENOMICS, INC.
|
|
|
SURFACE ANTIGENS OF MURINE T LYMPHOMAS
|
5R01CA040041-23
|
$311,649
|
$77,912
|
ALLISON, JAMES
|
SLOAN-KETTERING INSTITUTE FOR CANCER RES
|
|
|
Deformable registration for image-guided radiotherapy
|
5F32CA124138-02
|
$46,826
|
$46,826
|
Alterovitz, Ron
|
UNIVERSITY OF CALIFORNIA SAN FRANCISCO
|
|
|
Molecular targeting of the survivin pathway in cancer
|
5R01CA090917-09
|
$288,775
|
$14,439
|
Altieri, Dario
|
UNIV OF MASSACHUSETTS MED SCH WORCESTER
|
|
|
Maryland Prostate Cancer Case-Control Study
|
Z01 BC 010499
|
$336,383
|
$336,384
|
Ambs, Stefan
|
CCR (NCI)
|
|
|
The Molecular Profile of Prostate Tumors in African-American Men
|
Z01 BC 010624
|
$224,255
|
$224,256
|
Ambs, Stefan
|
CCR (NCI)
|
|
|
The Molecular Profile of Prostate Tumors in Smokers
|
Z01 BC 010660
|
$224,255
|
$224,256
|
Ambs, Stefan
|
CCR (NCI)
|
|
|
Non-coding RNAs as Prognostic and Diagnostic Markers in Prostate Cancer
|
Z01 BC 010886
|
$168,191
|
$168,192
|
Ambs, Stefan
|
CCR (NCI)
|
|
|
Biochemical Analysis of Multidrug Resistance-linked Transport Proteins
|
Z01 BC 010030
|
$863,565
|
$129,535
|
Ambudkar, Suresh
|
CCR (NCI)
|
|
|
Sweden and Denmark linked registries on hospital discharges and subsequent cancer
|
Z01 CP010183-00560
|
$4,450
|
$890
|
Anderson, William
|
DCEG (NCI)
|
|
|
Veterans Administration hospitalization database, Patient Treatment File, and Out
|
Z01 CP010183-00580
|
$179,292
|
$8,965
|
Anderson, William
|
DCEG (NCI)
|
|
|
PROSTATE, LUNG, COLORECTAL AND OVARIAN (PLCO) CANCER SCREENING TRIAL - SCREENING
|
N01CN025516-089
|
$1,929,112
|
$482,278
|
ANDRIOLE, GERALD
|
WASHINGTON UNIV:1107522
|
|
|
Evaluation of antiangiogenic role of EM011, a novel tubulin-binding agent
|
1K99CA131489-01A1
|
$131,088
|
$65,544
|
ANEJA, RITU
|
GEORGIA STATE UNIVERSITY
|
|
|
Extension of Radiotherapy Research
|
5P01CA006294-44
|
$1,516,143
|
$151,614
|
ANG, K
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
|
|
Clinical Trials Involving Vaccine and Standard of Care Cancer Therapies
|
Z01 BC 010662
|
$370,133
|
$148,054
|
Arlen, Philip
|
CCR (NCI)
|
|
|
Development of Ets2-Inhibitors
|
1R15CA125724-01A2
|
$222,376
|
$111,188
|
ARYA, DEV
|
CLEMSON UNIVERSITY
|
|
|
Southeast Cancer Control Consortium, Inc
|
5U10CA045808-22
|
$1,906,536
|
$381,307
|
ATKINS, JAMES
|
SOUTHEAST CANCER CONTROL CONSORTIUM
|
|
|
Eastern Cooperative Oncology Group
|
5U10CA080775-10
|
$128,678
|
$1,287
|
ATKINS, MICHAEL
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
Total relevant funding to Prostate for this search: $285,400,863
|
